February 2022Volume 175, Issue 2
February 2022Volume 175, Issue 2
ORIGINAL RESEARCH
1. Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019
- A Repeated Cross-Sectional Study
2. Associations of Serum Testosterone and Sex Hormone–Binding Globulin With Incident Cardiovascular Events in Middle-Aged to Older Men
3. Comparison of a Hemostatic Powder and Standard Treatment in the Control of Active Bleeding From Upper Nonvariceal Lesions
- A Multicenter, Noninferiority, Randomized Trial
4. Comparative Effectiveness of an Automated Text Messaging Service for Monitoring COVID-19 at Home
5. Thiamine Supplementation in Patients With Alcohol Use Disorder Presenting With Acute Critical Illness
- A Nationwide Retrospective Observational Study
6. Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis
- A Randomized Trial
7. Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis
- A Nationwide Population-Based Cohort Study With Sibling Comparison Design
8. Firearm Purchasing During the COVID-19 Pandemic: Results From the 2021 National Firearms Survey
9. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine
- Secondary Analysis of a Randomized Trial
10. Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels
- A Randomized Controlled Trial
REVIEWS
11. Safety and Efficiency of Diagnostic Strategies for Ruling Out Pulmonary Embolism in Clinically Relevant Patient Subgroups
- A Systematic Review and Individual-Patient Data Meta-analysis
12. Video Teleconferencing for Disease Prevention, Diagnosis, and Treatment
- A Rapid Review
BEYOND THE GUIDELINES
13. When and How Would You Screen This Patient for Cervical Cancer?
- Grand Rounds Discussion From Beth Israel Deaconess Medical Center
SPECIAL ARTICLES
14. COVID-19: Challenging Clinical Questions
IDEAS AND OPINIONS
15. Rebooting Instrumental Activities of Daily Living for the 21st Century
16. COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
17. Treating Opioid Withdrawal in the Hospital: A Role for Short-Acting Opioids
EDITORIALS
18. Influenza-Related Morbidity in Pregnancy: A Call for Maternal Immunization
19. Testosterone and Cardiovascular Disease in Men
20. The Role of Hemostatic Powder in Endoscopic Hemostasis of Nonvariceal Upper Gastrointestinal Bleeding
21. Extending a Lifeline to Nonhospitalized Patients With COVID-19 Through Automated Text Messaging
22. What Contributes to Pregnancy Complications Among Women With Cervical Intraepithelial Neoplasia Grade 3?
23. Higher D-Dimer Thresholds for Excluding Pulmonary Embolism: No Lunch?
ON BEING A DOCTOR
24. Swan Song
LETTERS
25. Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008–2009 to 2017–2018
- Observation: Brief Research Reports
26. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
- Comment
- Response
27. Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults
- Comment
- Response
AD LIBITUM
28. Morning Groove
29. The restaurant
30. Villanelle in Honor of American Hospitals
IN THE CLINIC
31. Acute Gastrointestinal Bleeding
ACP JOURNAL CLUB
32. In patients with stable CVD receiving statins, evolocumab reduced acute arterial events across all vascular territories
33. In mild acute diverticulitis, outpatient therapy without antibiotics was noninferior to antibiotics
34. In patients hospitalized with COVID-19, therapeutic- vs. prophylactic-dose heparin did not reduce a composite outcome at 28 d
35. In high-risk inpatients with COVID-19, therapeutic- vs. standard-dose heparin reduced thromboembolism or death at 30 d
36. In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding
37. In patients hospitalized for COPD exacerbation, a PE diagnostic strategy + usual care did not improve outcomes
38. In suspected or provisionally diagnosed ACS, early CTCA did not reduce mortality or nonfatal MI at 1 y
39. In permanent AF with narrow QRS, AV junction ablation + CRT vs. rate-control drug therapy reduced mortality
40. In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding
41. In critically ill adults, IV fluid bolus infused at slower vs. faster rates did not differ for 90-d mortality
WEB EXCLUSIVES
42. Annals Graphic Medicine - Dr. Mom: Which Hospital Snack Are You?
43. Annals Graphic Medicine - A Box of Chocolates
44. Annals for Educators - February 2022
45. Annals for Hospitalists Inpatient Notes - Another Way That Hospitalists Can Fight COVID-19